Literature DB >> 19277793

Intraoperative assessment of pancreatic neck margin at the time of pancreaticoduodenectomy increases likelihood of margin-negative resection in patients with pancreatic cancer.

Mary Dillhoff1, Robert Yates, Kristian Wall, Peter Muscarella, W Scott Melvin, E Christopher Ellison, Mark Bloomston.   

Abstract

BACKGROUND: The utility of intraoperative assessment of surgical margins is often debated by experienced pancreatic surgeons. We sought to review our experience with pancreaticoduodenectomy (PD) for pancreatic cancer to determine the impact of intraoperative frozen section (FS) analysis on margin-negative resection and long-term outcome.
MATERIAL AND METHODS: Between 1992 and 2007, 310 consecutive patients underwent PD at our institution; 223 of these were for pancreatic cancer. Seven patients who underwent R2 resection were excluded. Charts were reviewed to determine demographics, final pathology, perioperative course, and long-term outcome. Data were compared by Fisher's exact and Student's t tests. Survival curves were created using the Kaplan-Meier method and compared by log-rank analysis. Predictors of margin-negative resection were determined by logistic regression analysis and predictors of survival determined by Cox proportional hazards analysis.
RESULTS: FS analysis of pancreatic neck resection margins was obtained in 75, while no intraoperative assessment was done in 141. Although patients who underwent FS were younger (median, 62 vs. 67 years, p = 0.01), the two groups were similar in terms of gender, comorbidities, preoperative stenting, pylorus preservation, tumor differentiation, nodal status, tumor size, length of stay, and complication rate. Margin-negative resection was more common when FS was undertaken (99% vs. 81%, p = 0.0001). However, intraoperative FS did not significantly increase overall survival (median, 21.7 vs. 14.6, p = 0.20). Only nodal metastasis was predictive of poor survival (median, 21.7 vs. 13.3 months, p = 0.001).
CONCLUSIONS: Intraoperative assessment of the pancreatic neck margin status at the time of PD for pancreatic cancer increases the likelihood of obtaining a margin-negative resection. Noteworthy is that final margin status was not predictive of survival, while only nodal metastasis was, suggesting that tumor biology is the most important factor in patients with pancreatic cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19277793      PMCID: PMC3154842          DOI: 10.1007/s11605-009-0845-3

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  16 in total

Review 1.  Updates and controversies in the treatment of pancreatic cancer.

Authors:  Kavitha Kosuri; Peter Muscarella; Tanios S Bekaii-Saab
Journal:  Clin Adv Hematol Oncol       Date:  2006-01

Review 2.  Resection margins and R1 rates in pancreatic cancer--are we there yet?

Authors:  C S Verbeke
Journal:  Histopathology       Date:  2007-12-13       Impact factor: 5.087

3.  Most pancreatic cancer resections are R1 resections.

Authors:  Irene Esposito; Jörg Kleeff; Frank Bergmann; Caroline Reiser; Esther Herpel; Helmut Friess; Peter Schirmacher; Markus W Büchler
Journal:  Ann Surg Oncol       Date:  2008-03-20       Impact factor: 5.344

4.  A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer.

Authors:  Thomas J Howard; Joseph E Krug; Jian Yu; Nick J Zyromski; C Max Schmidt; Lewis E Jacobson; James A Madura; Eric A Wiebke; Keith D Lillemoe
Journal:  J Gastrointest Surg       Date:  2006-12       Impact factor: 3.452

5.  Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

Authors:  C J Yeo; R A Abrams; L B Grochow; T A Sohn; S E Ord; R H Hruban; M L Zahurak; W C Dooley; J Coleman; P K Sauter; H A Pitt; K D Lillemoe; J L Cameron
Journal:  Ann Surg       Date:  1997-05       Impact factor: 12.969

6.  Cancer statistics, 2007.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2007 Jan-Feb       Impact factor: 508.702

7.  Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma.

Authors:  C Max Schmidt; Jeffrey Glant; Jordan M Winter; Jason Kennard; Jennifer Dixon; Qianqian Zhao; Thomas J Howard; James A Madura; Atilla Nakeeb; Henry A Pitt; John L Cameron; Charles J Yeo; Keith D Lillemoe
Journal:  Surgery       Date:  2007-10       Impact factor: 3.982

8.  Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.

Authors:  Chandrajit P Raut; Jennifer F Tseng; Charlotte C Sun; Huamin Wang; Robert A Wolff; Christopher H Crane; Rosa Hwang; Jean-Nicolas Vauthey; Eddie K Abdalla; Jeffrey E Lee; Peter W T Pisters; Douglas B Evans
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

9.  Survival after resection for ductal adenocarcinoma of the pancreas.

Authors:  C Sperti; C Pasquali; A Piccoli; S Pedrazzoli
Journal:  Br J Surg       Date:  1996-05       Impact factor: 6.939

10.  Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?

Authors:  S S Nitecki; M G Sarr; T V Colby; J A van Heerden
Journal:  Ann Surg       Date:  1995-01       Impact factor: 12.969

View more
  12 in total

1.  Surgical management of adenocarcinoma of the pancreatic uncinate process in a cancer hospital in egypt.

Authors:  Sameh Roshdy; Osama Hussein; Ahmed Abdallah; Khaled Abdel-Wahab; Ahmed Senbel
Journal:  Clin Med Insights Gastroenterol       Date:  2015-01-14

2.  Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancer.

Authors:  Hanno Matthaei; Seung-Mo Hong; Skye C Mayo; Marco dal Molin; Kelly Olino; Raghunandan Venkat; Michael Goggins; Joseph M Herman; Barish H Edil; Christopher L Wolfgang; John L Cameron; Richard D Schulick; Anirban Maitra; Ralph H Hruban
Journal:  Ann Surg Oncol       Date:  2011-05-03       Impact factor: 5.344

3.  Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancer.

Authors:  Hanno Matthaei; Seung-Mo Hong; Skye C Mayo; Marco Dal Molin; Kelly Olino; Raghunandan Venkat; Michael Goggins; Joseph M Herman; Barish H Edil; Christopher L Wolfgang; John L Cameron; Richard D Schulick; Anirban Maitra; Ralph H Hruban
Journal:  Indian J Surg Oncol       Date:  2011-06-30

4.  Landmark Series: Importance of Pancreatic Resection Margins.

Authors:  Mihir M Shah; Jashodeep Datta; Nipun B Merchant; David A Kooby
Journal:  Ann Surg Oncol       Date:  2022-01-05       Impact factor: 5.344

Review 5.  Diagnosis and management of pancreatic cancer.

Authors:  A Collins; M Bloomston
Journal:  Minerva Gastroenterol Dietol       Date:  2009-12

6.  The association of adjuvant therapy with survival at the population level following pancreatic adenocarcinoma resection.

Authors:  Daniel J Kagedan; Ravish S Raju; Matthew E Dixon; Elizabeth Shin; Qing Li; Ning Liu; Maryam Elmi; Abraham El-Sedfy; Lawrence Paszat; Alexander Kiss; Craig C Earle; Nicole Mittmann; Natalie G Coburn
Journal:  HPB (Oxford)       Date:  2016-02-09       Impact factor: 3.647

7.  Revision of Surgical Margin under Frozen Section to Achieve R0 Status on Survival in Patients with Pancreatic Cancer.

Authors:  Zi Yin; Yu Zhou; Baohua Hou; Tingting Ma; Min Yu; Chuanzhao Zhang; Xin Lu; Zhixiang Jian
Journal:  J Gastrointest Surg       Date:  2018-05-18       Impact factor: 3.452

Review 8.  Advances in Diagnostic and Intraoperative Molecular Imaging of Pancreatic Cancer.

Authors:  Willemieke S Tummers; Juergen K Willmann; Bert A Bonsing; Alexander L Vahrmeijer; Sanjiv S Gambhir; Rutger-Jan Swijnenburg
Journal:  Pancreas       Date:  2018-07       Impact factor: 3.327

9.  Predictors of survival in periampullary cancers following pancreaticoduodenectomy.

Authors:  Ioannis Hatzaras; Nathaniel George; Peter Muscarella; W Scott Melvin; E Christopher Ellison; Mark Bloomston
Journal:  Ann Surg Oncol       Date:  2010-01-28       Impact factor: 5.344

10.  Detailed Analysis of Margin Positivity and the Site of Local Recurrence After Pancreaticoduodenectomy.

Authors:  Caitlin A McIntyre; Constantinos P Zambirinis; Alessandra Pulvirenti; Joanne F Chou; Mithat Gonen; Vinod P Balachandran; T Peter Kingham; Michael I D'Angelica; Murray F Brennan; Jeffrey A Drebin; William R Jarnagin; Peter J Allen
Journal:  Ann Surg Oncol       Date:  2020-05-25       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.